Cubist Systematic Strategies’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-20,338
| Closed | -$81K | – | 2643 |
|
|
2019
Q4 | $81K | Sell |
20,338
-3,865
| -16% | -$18.2K | ﹤0.01% | 2228 |
|
|
2019
Q3 | $119K | Sell |
24,203
-54,455
| -69% | -$305K | ﹤0.01% | 1900 |
|
|
2019
Q2 | $479K | Sell |
78,658
-59,714
| -43% | -$317K | 0.01% | 1500 |
|
|
2019
Q1 | $804K | Buy |
138,372
+126,904
| +1,107% | +$1.31M | 0.03% | 877 |
|
|
2018
Q4 | $154K | Sell |
11,468
-14,545
| -56% | -$245K | 0.01% | 1627 |
|
|
2018
Q3 | $505K | Buy |
26,013
+12,233
| +89% | +$260K | 0.03% | 821 |
|
|
2018
Q2 | $352K | Buy |
13,780
+11,453
| +492% | +$267K | 0.02% | 984 |
|
|
2018
Q1 | $47K | Sell |
2,327
-3,014
| -56% | -$70.3K | ﹤0.01% | 1705 |
|
|
2017
Q4 | $107K | Sell |
5,341
-31,823
| -86% | -$626K | 0.01% | 1675 |
|
|
2017
Q3 | $770K | Buy |
37,164
+2,177
| +6% | +$36.8K | 0.04% | 558 |
|
|
2017
Q2 | $518K | Buy |
+34,987
| New | +$583K | 0.03% | 725 |
|
|
2015
Q4 | – | Sell |
-23,622
| Closed | -$679K | – | 2052 |
|
|
2015
Q3 | $679K | Buy |
23,622
+9,322
| +65% | +$399K | 0.03% | 767 |
|
|
2015
Q2 | $640K | Buy |
+14,300
| New | +$538K | 0.03% | 818 |
|
Other funds holding DPLO
Cubist Systematic Strategies's DPLO Position: Q1 2020 in Review
Cubist Systematic Strategies sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 20,338 shares — an estimated $81K sold.
Cubist Systematic Strategies first reported a position in DPLO in Q2 2015 and held it in 13 quarters. The position peaked at $804K in Q1 2019. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.
- Cubist Systematic Strategies reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
- Cubist Systematic Strategies sold 20,338 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $81K.
- Cubist Systematic Strategies first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2015 and held it in 13 quarters.
- Cubist Systematic Strategies's DIPLOMAT PHARMACY, INC. position peaked at $804K in Q1 2019.
- 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.
Based on Cubist Systematic Strategies's 13F filing for Q1 2020, filed 15 May 2020.